Succinate dehydrogenase-deficient renal cell carcinoma: Detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma

Modern Pathology

Volumn 28, Issue 1, 2015, Pages 80-94

  Williamson, Sean R ^a   Eble, John N ^b   Amin, Mahul B ^c   Gupta, Nilesh S ^a   Smith, Steven C ^c   Sholl, Lynette M ^d   Montironi, Rodolfo ^e   Hirsch, Michelle S ^d   Hornick, Jason L ^d  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CADHERIN; CARBONATE DEHYDRATASE IX; CYTOKERATIN; CYTOKERATIN 7; CYTOKERATIN AE1; CYTOKERATIN AE3; CYTOKERATIN CAM5.2; EPITHELIAL MEMBRANE ANTIGEN; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE A; SUCCINATE DEHYDROGENASE B; TRANSCRIPTION FACTOR PAX8; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER MORPHOLOGY; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CELL INCLUSION; CELL VACUOLE; CLINICAL ARTICLE; DNA EXTRACTION; FEMALE; GERMLINE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUBULE; MALE; MAST CELL; METASTASIS; NEPHRECTOMY; NEXT GENERATION SEQUENCING; ONCOCYTOMA; ONCOGENE; PARAGANGLIOMA; SDHB GENE; DEFICIENCY; ENZYMOLOGY; GENETICS; HIGH THROUGHPUT SEQUENCING; KIDNEY TUMOR; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; SUCCINATE DEHYDROGENASE; YOUNG ADULT;

EID: 84920639883     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2014.86     Document Type: Article

References (35)

1. Barletta JA, Hornick JL. Succinate dehydrogenasedeficient tumors: diagnostic advances and clinical implications. Adv Anat Pathol 2012;19:193-203.
2. Gill AJ. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia. Pathology 2012;44:285-292.
3. Doyle LA, Hornick JL. Gastrointestinal stromal tumours: from KIT to succinate dehydrogenase. Histopathology 2014;64:53-67.
4. Ricketts CJ, Shuch B, Vocke CD, et al. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol 2012;188:2063-2071.
5. Housley SL, Lindsay RS, Young B, et al. Renal carcinoma with giant mitochondria associated with germ-line mutation and somatic loss of the succinate dehydrogenase B gene. Histopathology 2010;56:405-408.
6. Gill AJ, Pachter NS, Chou A, et al. Renal tumors associated with germline SDHB mutation show distinctive morphology. Am J Surg Pathol 2011;35:1578-1585.
7. Ricketts C, Woodward ER, Killick P, et al. Germline SDHB mutations and familial renal cell carcinoma. J Natl Cancer Inst 2008;100:1260-1262.
8. Miettinen M, Sarlomo-Rikala M, Cue PM, et al. Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms. Appl Immunohistochem Mol Morphol 2014;22:31-36.
9. Malinoc A, Sullivan M, Wiech T, et al. Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3. Endocr Relat Cancer 2012;19:283-290.
10. Papathomas TG, Gaal J, Corssmit EP, et al. Nonpheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCCPGL syndromes: a clinicopathological and molecular analysis. Eur J Endocrinol 2014;170:1-12.
11. Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of renal neoplasia. Am J Surg Pathol 2013;37:1469-1489.
12. Tickoo SK, Amin MB, Zarbo RJ. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining. Am J Surg Pathol 1998;22: 419-424.
13. Vanharanta S, Buchta M, McWhinney SR, et al. Earlyonset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet 2004;74:153-159.
14. Neumann HP, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292:943-951.
15. Srirangalingam U, Walker L, Khoo B, et al. Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers. Clin Endocrinol (Oxf) 2008;69:587-596.
16. Schimke RN, Collins DL, Stolle CA. Paraganglioma, neuroblastoma, and a SDHB mutation: resolution of a 30-year-old mystery. Am J Med Genet A 2010;152A: 1531-1535.
17. Henderson A, Douglas F, Perros P, et al. SDHBassociated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis. Fam Cancer 2009;8:257-260.
18. Ricketts CJ, Forman JR, Rattenberry E, et al. Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 2010;31:41-51.
19. Al-Ahmadie HA, Alden D, Fine SW, et al. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study. Am J Surg Pathol 2011;35:949-961.
20. Liu L, Qian J, Singh H, et al. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Arch Pathol Lab Med 2007;131:1290-1297.
21. Leroy X, Moukassa D, Copin MC, et al. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Eur Urol 2000;37:484-487.
22. Skinnider BF, Amin MB. An immunohistochemical approach to the differential diagnosis of renal tumors. Semin Diagn Pathol 2005;22:51-68.
23. Skinnider BF, Folpe AL, Hennigar RA, et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol 2005;29: 747-754.
24. Wang CC, Mao TL, Yang WC, et al. Underexpression of hepatocyte nuclear factor-1beta in chromophobe renal cell carcinoma. Histopathology 2013;62:589-594.
25. Kuehn A, Paner GP, Skinnider BF, et al. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications. Am J Surg Pathol 2007;31:1528-1533.
26. Tan PH, Cheng L, Rioux-Leclercq N, et al. Renal tumors: diagnostic and prognostic biomarkers. Am J Surg Pathol 2013;37:1518-1531.
27. Rao Q, Williamson SR, Zhang S, et al. TFE3 breakapart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Am J Surg Pathol 2013;37:804-815.
28. Green WM, Yonescu R, Morsberger L, et al. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service. Am J Surg Pathol 2013;37: 1150-1163.
29. Nese N, Martignoni G, Fletcher CD, et al. Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification. Am J Surg Pathol 2011;35:161-176.
30. He W, Cheville JC, Sadow PM, et al. Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors. Mod Pathol 2013;26:1355-1364.
31. Eble JN, Amin MB, Young RH. Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am J Surg Pathol 1997;21: 1123-1130.
32. Korpershoek E, Favier J, Gaal J, et al. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J Clin Endocrinol Metab 2011;96:E1472-E1476.
33. Wagner AJ, Remillard SP, Zhang YX, et al. Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors. Mod Pathol 2013;26: 289-294.
34. Miettinen M, Killian JK, Wang ZF, et al. Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation. Am J Surg Pathol 2013;37:234-240.
35. Gill AJ, Lipton L, Taylor J, et al. Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma. Pathology 2013;45:689-691.